Sanofi and Sobi's haemophilia partnership has been under competitive pressure from new therapies like Roche's antibody Hemlibra, so the two companies are hoping a new long-acting drug candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results